Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CL.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CL.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CL.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CL.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CL.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CL.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CL.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BM.1.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BM.1.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BM.1.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BM.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBMEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBMECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XBMECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBMEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBMEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.34EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.43.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.43.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.43.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.43.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.43.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.43.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EU.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EU.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used